Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.

about

Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

P2860

Q36219941-4F6F9F75-0648-4A22-820B-47BA929210B9 Q46241939-95B2664E-0B80-411D-ACD1-5701842C5E01

P2860

Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.

Item

http://www.wikidata.org/entity/Q35782951

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Recombinant BCG Expressing Myc ...... nst Experimental Buruli ulcer.

@ast

Recombinant BCG Expressing Myc ...... nst Experimental Buruli ulcer.

@en

type

Item

label

Recombinant BCG Expressing Myc ...... nst Experimental Buruli ulcer.

@ast

Recombinant BCG Expressing Myc ...... nst Experimental Buruli ulcer.

@en

prefLabel

Recombinant BCG Expressing Myc ...... nst Experimental Buruli ulcer.

@ast

Recombinant BCG Expressing Myc ...... nst Experimental Buruli ulcer.

@en

P1476

Recombinant BCG Expressing Myc ...... inst Experimental Buruli ulcer

@en

P2093

Laura P Hale

http://www.w3.org/2001/XMLSchema#string

Sunhee Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer

Buruli ulcer and mycolactone-producing mycobacteria

Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence

Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected mice

Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial.

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

Buruli ulcer in West Africa: strategies for early detection and treatment in the antibiotic era.

The Delta fbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells.

Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting

Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.

P304

e0004046

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PNTD.0004046

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bryan E Hart

P577

2015-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282133717

http://www.w3.org/2001/XMLSchema#string

P698

26393347

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium ulcerans

P932

4579011

http://www.w3.org/2001/XMLSchema#string

Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.

about

P2860

P2860

Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932